Search

Your search keyword '"Grossman, Craig E."' showing total 20 results
Start Over Author "Grossman, Craig E."
20 results on '"Grossman, Craig E."'

4. 40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy.

Author

Moore, Assaf, Zhigang Zhang, Teng Fei, Lei Zhang, Accomando, Laura, Schmitt, Adam M., Higginson, Daniel S., Mueller, Boris A., Zinovoy, Melissa, Gelblum, Daphna Y., Yerramilli, Divya, Xu, Amy J., Brennan, Victoria S., Guttmann, David M., Grossman, Craig E., Dover, Laura L., Shaverdian, Narek, Pike, Luke R. G., Cuaron, John J., and Dreyfuss, Alexandra

Published
2024
Full Text
View/download PDF

5. Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer

Author

Moore, Assaf, primary, Kollmeier, Marisa A., additional, McBride, Sean M., additional, Toumbacaris, Nicolas, additional, Zhang, Zhigang, additional, Lacy-Elsayegh, Ahmed, additional, Dreyfuss, Alexandra, additional, Grossman, Craig E., additional, Gorovets, Daniel, additional, and Zelefsky, Michael J., additional

Published
2023
Full Text
View/download PDF

7. Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiotherapy and Association of Metric Score with Rectal Toxicity Outcomes

Author

Grossman, Craig E., primary, Folkert, Michael R., additional, Lobaugh, Stephanie, additional, Desai, Neil B., additional, Rezaeian, Nima H., additional, Kollmeier, Marisa A., additional, Gorovets, Daniel, additional, Shasha, Daniel, additional, McBride, Sean M., additional, Timmerman, Robert D., additional, Hannan, Raquibul, additional, Zhang, Zhigang, additional, and Zelefsky, Michael J., additional

Published
2023
Full Text
View/download PDF

18. Fluence Rate Differences in Photodynamic Therapy Efficacy and Activation of Epidermal Growth Factor Receptor after Treatment of the Tumor-Involved Murine Thoracic Cavity.

Author

Grossman, Craig E., Carter, Shirron L., Czupryna, Julie, Le Wang, Putt, Mary E., and Busch, Theresa M.

Subjects
*PHOTODYNAMIC therapy, *EPIDERMAL growth factor receptors, *OPTICAL imaging sensors, *CHEST (Anatomy), *NON-small-cell lung carcinoma
Abstract

Photodynamic therapy (PDT) of the thoracic cavity can be performed in conjunction with surgery to treat cancers of the lung and its pleura. However, illumination of the cavity results in tissue exposure to a broad range of fluence rates. In a murine model of intrathoracic PDT, we studied the efficacy of 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH; Photochlor®)-mediated PDT in reducing the burden of non-small cell lung cancer for treatments performed at different incident fluence rates (75 versus 150 mW/cm). To better understand a role for growth factor signaling in disease progression after intrathoracic PDT, the expression and activation of epidermal growth factor receptor (EGFR) was evaluated in areas of post-treatment proliferation. The low fluence rate of 75 mW/cm produced the largest reductions in tumor burden. Bioluminescent imaging and histological staining for cell proliferation (anti-Ki-67) identified areas of disease progression at both fluence rates after PDT. However, increased EGFR activation in proliferative areas was detected only after treatment at the higher fluence rate of 150 mW/cm. These data suggest that fluence rate may affect the activation of survival factors, such as EGFR, and weaker activation at lower fluence rate could contribute to a smaller tumor burden after PDT at 75 mW/cm. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

20. 131 I Sodium Iodide

Author

Weeks S and Grossman CE

Abstract

Radioiodine-131 is a therapeutic agent used in the management and treatment of hyperthyroidism and thyroid carcinoma. This activity describes the indications, mechanism of action, and contraindications for radioiodine-131 as a treatment for Graves disease, toxic adenoma, toxic multinodular goiter, and differentiated thyroid carcinoma. This activity will highlight information pertinent to members of the interprofessional healthcare team in the use of radioiodine-131 therapy., (Copyright © 2022, StatPearls Publishing LLC.)

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results